| Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial FX Lescure, H Honda, RA Fowler, JS Lazar, G Shi, P Wung, N Patel, ... The Lancet Respiratory Medicine 9 (5), 522-532, 2021 | 279 | 2021 |
| Utility of hyposmia and hypogeusia for the diagnosis of COVID-19 F Bénézit, P Le Turnier, C Declerck, C Paillé, M Revest, V Dubée, ... The Lancet Infectious Diseases 20 (9), 1014-1015, 2020 | 272 | 2020 |
| The esc-eorp euro-endo (european infective endocarditis) registry G Habib, P Lancellotti, PA Erba, A Sadeghpour, M Meshaal, A Sambola, ... European Heart Journal-Quality of Care and Clinical Outcomes 5 (3), 202-207, 2019 | 87 | 2019 |
| Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis M Lefebvre, C Jacqueline, G Amador, V Le Mabecque, A Miegeville, ... International journal of antimicrobial agents 36 (6), 542-544, 2010 | 76 | 2010 |
| Prevalence of and factors associated with depression among people living with HIV in France P Feuillet, F Lert, L Tron, C Aubriere, B Spire, R Dray‐Spira, ... HIV medicine 18 (6), 383-394, 2017 | 70 | 2017 |
| Hepatitis C virus incidence in HIV‐infected and in preexposure prophylaxis (PrEP)‐using men having sex with men L Cotte, E Cua, J Reynes, F Raffi, D Rey, P Delobel, A Gagneux‐Brunon, ... Liver International 38 (10), 1736-1740, 2018 | 60 | 2018 |
| First isolation of Tropheryma whipplei from bronchoalveolar fluid and clinical implications F Fenollar, T Ponge, B La Scola, JC Lagier, M Lefebvre, D Raoult Journal of Infection 65 (3), 275-278, 2012 | 53 | 2012 |
| Rickettsia sibirica mongolitimonae in traveler from Egypt C Socolovschi, S Barbarot, M Lefebvre, P Parola, D Raoult Emerging infectious diseases 16 (9), 1495, 2010 | 45 | 2010 |
| Ageing with HIV: do comorbidities and polymedication drive treatment optimization? L Cuzin, C Katlama, L Cotte, P Pugliese, A Cheret, C Bernaud, D Rey, ... HIV medicine 18 (6), 395-401, 2017 | 42 | 2017 |
| Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study A Ursenbach, V Max, M Maurel, F Bani-Sadr, A Gagneux-Brunon, ... Journal of Antimicrobial Chemotherapy 75 (11), 3344-3348, 2020 | 41 | 2020 |
| Systemic immune presentations of Coxiella burnetii infection (Q Fever) M Lefebvre, O Grossi, C Agard, C Perret, P Le Pape, D Raoult, ... Seminars in arthritis and rheumatism 39 (5), 405-409, 2010 | 41 | 2010 |
| Evaluation of the acceptability in France of the vaccine against papillomavirus (HPV) among middle and high school students and their parents JF Huon, A Gregoire, A Meireles, M Lefebvre, M Péré, J Coutherut, ... PLoS One 15 (10), e0234693, 2020 | 36 | 2020 |
| Tungiasis: a poorly documented tropical dermatosis M Lefebvre, C Capito, C Durant, B Hervier, O Grossi Médecine et maladies infectieuses 41 (9), 465-468, 2011 | 33 | 2011 |
| Characteristics, management, and outcomes of patients with left‐sided infective endocarditis complicated by heart failure: a substudy of the ESC‐EORP EURO‐ENDO (European … Y Bohbot, G Habib, C Laroche, E Stöhr, C Chirouze, ... European journal of heart failure 24 (7), 1253-1265, 2022 | 32 | 2022 |
| Factors associated with deaths from suicide in a French nationwide HIV‐infected cohort M Hentzien, A Cabié, P Pugliese, É Billaud, I Poizot‐Martin, C Duvivier, ... HIV medicine 19 (8), 551-558, 2018 | 31 | 2018 |
| Should we reconsider cefazolin for treating staphylococcal meningitis? A retrospective analysis of cefazolin and cloxacillin cerebrospinal fluid levels in patients treated for … P Le Turnier, M Grégoire, G Deslandes, K Lakhal, C Deschanvres, ... Clinical Microbiology and Infection 26 (10), 1415. e1-1415. e4, 2020 | 29 | 2020 |
| Vertebral osteomyelitis: an unusual presentation of Bartonella henselae infection J Graveleau, O Grossi, M Lefebvre, H Redon, JM Caignon, A Pallardy, ... Seminars in arthritis and rheumatism 41 (3), 511-516, 2011 | 28 | 2011 |
| Safety and immunogenicity of a variant-adapted SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant as a booster in adults primed with authorized vaccines: a phase 3 … G de Bruyn, J Wang, A Purvis, MS Ruiz, H Adhikarla, S Alvi, MI Bonaparte, ... EClinicalMedicine 62, 2023 | 21 | 2023 |
| COVID-19 vaccines: Frequently asked questions and updated answers M Lefebvre, N Vignier, B Pitard, E Botelho-Nevers, B Wyplosz, R Cohen, ... Infectious diseases now 51 (4), 319-333, 2021 | 21 | 2021 |
| Severe symptomatic primary human cytomegalovirus infection despite effective innate and adaptive immune responses R Riou, C Bressollette-Bodin, D Boutoille, K Gagne, A Rodallec, ... Journal of Virology 91 (5), 10.1128/jvi. 02245-16, 2017 | 19 | 2017 |
